Jean GIRARD, Professor Emeritus at University of Paris, President of the FFRD Scientific Council
“ I worked all my life on the hormonal regulation of metabolism first during development then in adults (Faculty of Sciences, College de France, CNRS, INSERM then University of Paris 5). I gained experience in assessing research (specifically as member and President of the specialized Commission of INSERM) and I participated as Scientific Advisor from HCERES for the evaluation of research units CNRS, INSERM and University of life Sciences. As President of the FFRD Scientific Council, since its creation in 2013, my main role is to organize, with the FFRD‘s President and the Office, the evaluation of research projects by the Scientific Council (choice of international experts, rapporteurs within the SC and the renewal of the SC members) ”.
Claude CHAUMEIL, Vice-President, in charge of the patients strategy of the French Federation of Diabetes (FFD), Vice-President of the FFRD
“ The figures speak for themselves – there is an urgency to mobilise against diabetes. This mobilisation must also involve researchers. The creation of the FFRD must promote scientific and medical advances on this genetic and hereditary disease. The AFD, directed by and for patients, provides its financial assistance to FFRD. It wants to be the stimulus for the researchers to find paths to recovery ”.
Claude JAFFIOL, Professor of Endocrinology Metabolism, Member of the French National Academy of Medicine
“ The French National Academy of Medicine that represent is incomplete harmony with the objectives of the FFRD. I myself am very attached to contributing to and facilitating the development of research projects supported by the Foundation in the domain of epidemiology and in the development of therapeutic education. As a result I feel very committed to policy followed by this institution”.
Christian BOITARD, Professor of Diabetology, INSERM representative
“INSERM supports the efforts of the FFRD, which was created with the mission of structuring activities in the research on diabetes and upstream research on its most applied aspects. Because of its frequency, diabetes is a major health challenge, outstanding for a number of reasons. The future is in the discovery of new biological markers of the many diseases that overlap the term diabetes, a new nosologic definition of these diseases, and the definition of therapeutic approaches toward their prevention. These are the common missions of the FFRD and INSERM”.